This is what the Hungarian COVID medicine will be capable of
Change language:
More information about the Hungarian coronavirus drug appeared in the program of InfoRádió. Immunologist Imre Kacskovics helps clear up who will receive the medicine.
Hungarian COVID medicine is on the way
Imre Kacskovics, the Dean of the Faculty of Science of Eötvös Loránd University, spoke to InfoRádió. He stated that clinical testing will begin in early 2023. Before that, they are performing animal experiments and toxicological tests, writes index.hu.
“We’ve been able to identify molecules that are new. They’re new in the sense that we think they’re patentable. And we’ve been able to detect these molecules and drugs in the summer to prevent the virus from infecting cells,” Kacskovics said.
Animal experiments are currently underway.
“We are very confident that these experiments will be successful and we will be able to select the molecule that we will take further through drug development.” With this, Kacskovics referred to what phases precede the clinical phase.
Clinical testing of the Hungarian drug will begin in 2023
The toxicological tests show whether the medicine prevents infection. It is also important to note that the drug does not cause any other illness.